This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Pontifica Universidad Catoclica De Chile, Pontificia Universidad Catòlica De Chile. Active years: 2023-2025.
Company Filing History:
2 out of 3,690 
1 out of 1 
1 out of 43 
Years Active: 2023-2025
Title: The Innovative Contributions of Andres E Dulcey
Introduction
Andres E Dulcey is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target specific pathways in the brain. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Dulcey's latest patents focus on c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same. These compounds are designed to inhibit c-Abl tyrosine kinase, which plays a crucial role in several cellular pathways. The novel c-Abl inhibitors can bind to c-Abl at an allosteric site, effectively inhibiting its activity. Importantly, these compounds are capable of crossing the blood-brain barrier, making them useful for treating diseases that involve c-Abl, such as cancers, motor neuron diseases, and neurodegenerative diseases. The patents also disclose methods for making and utilizing these c-Abl inhibitory compounds.
Career Highlights
Throughout his career, Dulcey has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Pontificia Universidad Catolica De Chile. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Juan Jose Marugan and Marc Ferrer. Their collaborative efforts have further advanced the research and development of innovative therapeutic agents.
Conclusion
Andres E Dulcey is a distinguished inventor whose work in developing c-Abl inhibitors holds promise for treating various diseases. His contributions to biomedical research continue to pave the way for innovative therapeutic solutions.